I take it by "watch developments with first patient" you don't mean that you are holding from now until then, about 10 months longer than most of your scalps or 1-3 day swings. Just curious is all.
Yeah, I'll be "watching" too, but not with money in the game until something happens, since all of our great short term catalysts just evaporated into thin air -- no uplist in the next couple months with share price so low, no trials start for 6 to 8 months, FDA hydrogel application date in limbo now that schedules are being "re-evaluated" according to CEO and will undoubtedly get pushed back into 2014, and lastly, the preliminary results of the first patient would be 3 months after patient enrollment, which takes us to around May of next year.
Until those events get closer, there are zero catalysts to value the stock any higher than it is, but meanwhile there are other shoes that could drop any time now, like you were saying a couple days ago, the timeline extension for hydrogel bombshell PR which is coming any day now.
More importantly, there is a distinct possibility, not to be discounted, that we could see an investigation into CEO intentionally misleading investors and shareholders on schedule, possible overt and intentional editing and manipulation of videos and study results -- maybe even outright fabrication of videos, since ex-CEO was in a court battle with U of Penn and Wharton in 2008-2010 over the school name he could use on his master's degree, and the court had evidence that Frank literally fabricated and backdated a powerpoint which supposedly was promotional promises from the university. Those things in combination with Frank's exaggeration over how many monkeys improved under what conditions leads me to believe some type of official investigation could be forthcoming if shorts put out a highly detailed analysis of frank's promotional materials. That would be bad, REAL BAD for the stock price, even with him gone, as the adverse publicity might make FDA take a step back and reconsider scaffold tests.
AI
